Lonza Group Investor Relations Material
Latest events
Investor Update
Lonza Group
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Lonza Group AG
Access all reports
Lonza Group Ltd. engages in the manufacture and supply of products and services to the pharmaceutical, biotechnology, and diagnostic sectors. It operates through the Pharma & Biotech and Specialty Ingredients segments. The Pharma & Biotech segment includes active pharmaceutical ingredient active substances for therapeutic drugs for bacterial infections, anti-fungals, anti-virals, anti-cancer agents, cardiovasculars, gastrointestinal, and others. The Specialty Ingredients segment involves in the cosmetics ingredients business for personal care. Lonza Group was founded on December 5, 1897 and is headquartered in Basel.
Key slides for Lonza Group AG
CMD 2023
Lonza Group AG
H2 2023
Lonza Group AG
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇨🇭 Switzerland